Back

Social and Polygenic Risk Factors for Time to Comorbid Diagnoses in Individuals with Substance Use Disorders: A Phenome-Wide Survival Analysis

Barr, P. B.; Neale, Z. E.; Bigdeli, T. B.; Chatzinakos, C.; Harvey, P. D.; Peterson, R. E.; Meyers, J. L.

2024-12-14 epidemiology
10.1101/2024.12.13.24319000
Show abstract

ObjectivePersons with substance use disorders (SUD) often suffer from additional comorbidities. Researchers have explored this overlap via phenome wide association studies (PheWAS). However, PheWAS are largely cross-sectional, limiting our understanding of whether diagnoses predate development of an SUD. We characterize whether polygenic scores (PGS) are associated with time to comorbid diagnoses in electronic health records (EHR) after the first documented SUD diagnosis. MethodsUsing data from All of Us (N = 393,596), we explored: 1) whether social determinants of health (SDoH) are associated with lifetime risk of SUD (N cases = 42,568) and 2) within a subset those with a diagnosed SUD and available genetic data SUD (N = 21,357), whether PGS for alcohol use disorders, cannabis use disorders, depression, externalizing, post-traumatic stress disorder, and schizophrenia were associated with subsequent diagnoses via a phenome-wide survival analysis. ResultsMultiple SDoH were associated with lifetime SUD diagnosis, with annual household income having the largest overall associations (e.g., <$10K annually vs $100K-$150K annually: OR = 3.89, 95% CI = 3.66, 4.13). There were 101 phenome-wide significant PGS associations with subsequent diagnoses across various bodily systems. PGSs for alcohol use disorders, post-traumatic stress disorder, and schizophrenia were each associated with time to their respective diagnoses. ConclusionsSocial determinants, especially those related to income, have profound associations with lifetime SUD risk. Additionally, PGS for psychiatric conditions are associated with multiple post-SUD diagnoses within those with a SUD, suggesting PGS may capture information beyond lifetime risk, including timing and severity of comorbidities related to SUD.

Matching journals

1
Drug and Alcohol Dependence
Elsevier BV · based on 21 published papers
Top 0.3%
110× avg
2
Translational Psychiatry
Springer Science and Business Media LLC · based on 94 published papers
Top 2%
20× avg
3
Addiction
Wiley · based on 24 published papers
Top 0.6%
47× avg
4
American Journal of Psychiatry
American Psychiatric Association Publishing · based on 14 published papers
#1
97× avg
5
JAMA Network Open
American Medical Association (AMA) · based on 125 published papers
Top 4%
6.2× avg
6
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 77%
3.0%
7
Psychological Medicine
Cambridge University Press (CUP) · based on 52 published papers
Top 3%
8.6× avg
8
JAMA Psychiatry
American Medical Association (AMA) · based on 11 published papers
#1
68× avg
9
Molecular Psychiatry
Springer Science and Business Media LLC · based on 84 published papers
Top 3%
8.6× avg
10
Journal of Affective Disorders
Elsevier BV · based on 72 published papers
Top 4%
5.8× avg
11
PLOS Medicine
Public Library of Science (PLoS) · based on 95 published papers
Top 6%
4.4× avg
12
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 65%
2.3%
13
Biological Psychiatry Global Open Science
Elsevier BV · based on 23 published papers
Top 2%
17× avg
14
Neuropsychopharmacology
Springer Science and Business Media LLC · based on 29 published papers
Top 2%
13× avg
15
Nature Human Behaviour
Springer Science and Business Media LLC · based on 18 published papers
Top 0.8%
15× avg
16
Clinical Infectious Diseases
Oxford University Press (OUP) · based on 219 published papers
Top 14%
1.6× avg
17
American Journal of Epidemiology
Oxford University Press (OUP) · based on 54 published papers
Top 4%
6.3× avg
18
SSM - Population Health
Elsevier BV · based on 17 published papers
Top 1%
18× avg
19
BMC Medicine
Springer Science and Business Media LLC · based on 155 published papers
Top 16%
1.7× avg
20
JAIDS Journal of Acquired Immune Deficiency Syndromes
Ovid Technologies (Wolters Kluwer Health) · based on 18 published papers
Top 1%
14× avg
21
BMC Public Health
Springer Science and Business Media LLC · based on 148 published papers
Top 21%
0.8%
22
Psychiatry Research
Elsevier BV · based on 33 published papers
Top 5%
4.2× avg
23
Epidemiology
Ovid Technologies (Wolters Kluwer Health) · based on 26 published papers
Top 2%
9.9× avg
24
Frontiers in Public Health
Frontiers Media SA · based on 135 published papers
Top 25%
0.8%
25
The British Journal of Psychiatry
Royal College of Psychiatrists · based on 21 published papers
Top 3%
5.8× avg
26
BMJ Mental Health
BMJ · based on 15 published papers
Top 2%
11× avg
27
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Elsevier BV · based on 10 published papers
Top 1%
13× avg
28
International Journal of Drug Policy
Elsevier BV · based on 11 published papers
Top 0.9%
13× avg
29
Journal of Epidemiology and Community Health
BMJ · based on 32 published papers
Top 5%
4.2× avg
30
Journal of Child Psychology and Psychiatry
Wiley · based on 18 published papers
Top 2%
9.0× avg